open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

61. The outcomes of the conventionally fractionated radiotherapy in the prospectiive and retrosprctive studies. Is the meaning of conventionality the same?

A. Hliniak, W. Michalski, Z. Szutkowski, E. Kraszewska, A. Jarząbski
DOI: 10.1016/S1507-1367(01)70431-2
·
Rep Pract Oncol Radiother 2001;6(1):55-56.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

Aim

To discuss some problems of the “conventionality” in the prospective and retrospective studies finished last year at the RT Department in Warsaw. The phase III clinical trial. The study was conducted according to the evidence based rules. Cancer of the larynx – glottis and supragiottis T1 – T3 NO M0 WHO 0 – 1, 395 cases 196 in experimental, 199 in conventional arm. The retrospective study concerned all patients with the cancer of larynx treated radically in the II department in years 1989 to May 1995. 372 patients T1- T4, N1-N3, M0. The prospective material 150 patients were selected [age 75 and less, WHO 0–1, T1–T3, NO, M0] employing the same selection criteria as in the prospective study. The comparison was performed with the conventional arm of the clinical trial [199 cases].

Results of the study

Significant differences were recorded in the: ? performance status and in the number of T1 and T3 cases, ? compliance to protocol in the total dose and the overall treatment time, ? response to treatment in the whole group and in the particular stages These results indicate the very demanding selection of cases and much more rigorous compliance with the therapeutic protocol in the prospective study. The response to treatment was about 20% higher in the clinical trial group. The 20% difference between the outcomes in the prospective and retrospective studies recorded in the response to treatment was similar in the 1, 2, and 3 years local control observations.

Abstract

Aim

To discuss some problems of the “conventionality” in the prospective and retrospective studies finished last year at the RT Department in Warsaw. The phase III clinical trial. The study was conducted according to the evidence based rules. Cancer of the larynx – glottis and supragiottis T1 – T3 NO M0 WHO 0 – 1, 395 cases 196 in experimental, 199 in conventional arm. The retrospective study concerned all patients with the cancer of larynx treated radically in the II department in years 1989 to May 1995. 372 patients T1- T4, N1-N3, M0. The prospective material 150 patients were selected [age 75 and less, WHO 0–1, T1–T3, NO, M0] employing the same selection criteria as in the prospective study. The comparison was performed with the conventional arm of the clinical trial [199 cases].

Results of the study

Significant differences were recorded in the: ? performance status and in the number of T1 and T3 cases, ? compliance to protocol in the total dose and the overall treatment time, ? response to treatment in the whole group and in the particular stages These results indicate the very demanding selection of cases and much more rigorous compliance with the therapeutic protocol in the prospective study. The response to treatment was about 20% higher in the clinical trial group. The 20% difference between the outcomes in the prospective and retrospective studies recorded in the response to treatment was similar in the 1, 2, and 3 years local control observations.

Get Citation
About this article
Title

61. The outcomes of the conventionally fractionated radiotherapy in the prospectiive and retrosprctive studies. Is the meaning of conventionality the same?

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

55-56

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70431-2

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):55-56.

Authors

A. Hliniak
W. Michalski
Z. Szutkowski
E. Kraszewska
A. Jarząbski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl